WAM
AHCO icon

Wakefield Asset Management’s AdaptHealth AHCO Stock Holding History

Wakefield Asset Management’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-87,494
Closed -$1.01M – 144
2024
Q1 		$1.01M Buy
+87,494
New +$743K 0.35% 81

Other funds holding AHCO

OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $74.2B AUM 21.09% 1-Year Est. Return

Wakefield Asset Management's AHCO Position: Q2 2024 in Review

Wakefield Asset Management sold out of AdaptHealth (AHCO) in Q2 2024, closing a stake of 87,494 shares — an estimated $1.01M sold.

Wakefield Asset Management first reported a position in AHCO in Q1 2024 and held it in 1 quarter. The position peaked at $1.01M in Q1 2024. 207 funds tracked by Wall St. Rank hold AHCO as of Q2 2024.

  • Wakefield Asset Management reported no remaining AdaptHealth position as of Q2 2024 after selling out during the quarter.
  • Wakefield Asset Management sold 87,494 AdaptHealth shares in Q2 2024, an estimated $1.01M.
  • Wakefield Asset Management first reported a position in AdaptHealth in Q1 2024 and held it in 1 quarter.
  • Wakefield Asset Management's AdaptHealth position peaked at $1.01M in Q1 2024.
  • 207 funds tracked by Wall St. Rank held AdaptHealth as of Q2 2024.

Based on Wakefield Asset Management's 13F filing for Q2 2024, filed 5 Aug 2024.